Evaluating the Sustained Therapeutic Necessity and Patient Compliance Challenges Driving Imatinib Drug Market Demands Worldwide The persistent and growing Imatinib Drug Market Demands stem directly from the irreplaceable role imatinib plays as a targeted therapeutic agent for Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML). Since its introduction, imatinib has transformed CML from a near-fatal condition into a manageable chronic disease, meaning patients require the medication for extended, often indefinite, periods to maintain molecular remission. This long-term usage Ref - https://www.marketresearchfuture.com/reports/imatinib-drug-market-42762